NR4A1 and breast cancer: Our study investigated the relationship between the FCGR3A-V158F polymorphism and the clinicopathological characteristics of breast cancer patients, including age, family history, TNM staging, tumor size, lymph nodes, histopathological grade, and hormonal receptor status.